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Abstract
Trypanosoma cruzi, the agent of Chagas disease, is a complex of genetically diverse isolates highly phylogenetically related
to T. cruzi-like species, Trypanosoma cruzi marinkellei and Trypanosoma dionisii, all sharing morphology of blood and culture
forms and development within cells. However, they differ in hosts, vectors and pathogenicity: T. cruzi is a human pathogen
infective to virtually all mammals whilst the other two species are non-pathogenic and bat restricted. Previous studies
suggest that variations in expression levels and genetic diversity of cruzipain, the major isoform of cathepsin L-like (CATL)
enzymes of T. cruzi, correlate with levels of cellular invasion, differentiation, virulence and pathogenicity of distinct strains. In
this study, we compared 80 sequences of genes encoding cruzipain from 25 T. cruzi isolates representative of all discrete
typing units (DTUs TcI-TcVI) and the new genotype Tcbat and 10 sequences of homologous genes from other species. The
catalytic domain repertoires diverged according to DTUs and trypanosome species. Relatively homogeneous sequences are
found within and among isolates of the same DTU except TcV and TcVI, which displayed sequences unique or identical to
those of TcII and TcIII, supporting their origin from the hybridization between these two DTUs. In network genealogies,
sequences from T. cruzi clustered tightly together and closer to T. c. marinkellei than to T. dionisii and largely differed from
homologues of T. rangeli and T. b. brucei. Here, analysis of isolates representative of the overall biological and genetic
diversity of T. cruzi and closest T. cruzi-like species evidenced DTU- and species-specific polymorphisms corroborating
phylogenetic relationships inferred with other genes. Comparison of both phylogenetically close and distant trypanosomes
is valuable to understand host-parasite interactions, virulence and pathogenicity. Our findings corroborate cruzipain as
valuable target for drugs, vaccine, diagnostic and genotyping approaches.
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Introduction
Cathepsin L-like (CATL) are cysteine proteases that play
important roles in cell invasion, growth, differentiation, immunity,
immune-modulation, virulence, pathogenicity and survival of
pathogenic protozoans. Different isoforms of CATL are encoded
by a large gene family and perform distinct roles in the interactions
of the trypanosomes with vertebrate hosts and vectors, differing in
stage, cellular localization and expression level during the life
cycle. This functional and structural diversification may have
contributed to the adaptation of different trypanosome species to
their different life cycles, vertebrate hosts and vectors [1–4].
Trypanosoma cruzi is the type species of the subgenus Schizotryp-
anum and a complex of genetically heterogeneous isolates
distributed in 6 intraspecific subdivisions denominated discrete
typing units (DTUs), TcI-TcVI [5,6], and one new genotype
(Tcbat) identified in Brazilian bats [7]. Closest relatives of T. cruzi
are the bat-restricted T. c. marinkellei followed by T. dionisii, which
are referred as T. cruzi-like due to morphologically indistinguish-
able blood and culture forms [8–11]. Development within
mammalian cells in vitro is a feature shared by all species of the
subgenus Schizotrypanum, while in vivo only T. cruzi has been proven
to infect mammals other than chiropterans [7,9,10,12–14]. Bats
infected by T. cruzi-like species show nests of amastigotes in
cardiac, skeletal and stomach muscle cells likewise T. cruzi in a
range of hosts including man. Recent studies demonstrated that T.
dionisii and T. cruzi invade mammalian cells through a common
mechanism involving lysosome mobilization to the site of parasite
entry [15,16]. Previous studies showed that T. cruzi and T. dionisii
share similar molecules with important roles in host-parasite
interactions such as phospholipids and cysteine proteases [17,18]
as well as epitopes associated to autoimmunity in Chagas disease
[19]. Nevertheless, T. dionisii differ from T. cruzi in surface
glycoproteins involved in host-cell interactions [16]. Besides
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morphology and in vitro and in vivo behavior, T. cruzi-like species
share cellular, biochemical and immunological features with T.
cruzi and, hence, can be valuable as non-infective to humans
models for studies of T. cruzi and as targets for trials of drugs,
vaccines and diagnosis [10,20].
Similar to T. cruzi, all T. cruzi-like isolates differentiate from
epimastigotes to infective metacyclic trypomastigotes in cultures
and in the vector gut; bats are infected by licking vector feces
contaminated with trypanosomes on their fur and/or by ingesting
the infected vectors themselves [8,9]. Differently from T. cruzi that
can be transmitted by several genera of triatomine bugs,
transmission of T. c. marinkellei seems to involve only triatomines
of the genus Cavernicola, while cimicids are vectors of T. dionisii
[8,9]. In addition to T. cruzi, T. rangeli was reported infecting
humans and non-human primates, chiropterans and mammals of
other orders and are both transmitted by triatomines [21,22]. The
mechanisms underpinning vertebrate and vector specificities of
these trypanosomes are unknown.
Previous studies demonstrated that two main CATL enzymes
are expressed by T. cruzi, the major isoform (.75 copies)
addressed in the present study and designated as cruzipain, is
the archetype of a large multigene family organized in tandem
repeats expressed in all life cycle stages of T. cruzi [4,23–26].
Analysis of polymorphic cruzipain-encoding genes disclosed the
isoform cruzipain 2 (,6 copies), which is expressed preferentially
by the mammalian stages and differs markedly from cruzipain
with respect to substrate specificity and kinetic properties [27,28].
Cruzipain plays fundamental functions in T. cruzi life cycle with
recognized roles in parasite-host interactions, in establishing,
maintaining, exacerbating and controlling infections. There are
increasing evidence that the immunopathogenesis of experimental
Chagas Disease is, at least in part, due to the activity of cruzipain
mediating cell invasion, inflammation, tissue damage and immune
evasion [29,30]. Cruzipain is an immunodominat antigen,
expressed on parasite surface and secreted, which elicits potent
humoral [31,32] and cellular immune responses in T. cruzi infected
humans and mice [33,34]. Vaccination with recombinant
cruzipain trigger strong humoral and cell-mediated immunity
controlilng parasite load and inflammatory tissue damage [34–37].
Addition of synthetic irreversible inhibitors to cultures of cells
infected with T. cruzi blocks parasite replication, intracellular
growth and differentiation [38,39]. Treatment of T. cruzi infected
mice with inhibitors designed to inactivate cruzipain rescued mice
from a lethal infection [40]. T. cruzi ability to invade human cells
was modulated by the balance between cruzipain and chagasin, a
natural endogenous inhibitor of papain-like cysteine proteases
[41,42]. Therefore, inhibitors of cruzipain are among the most
promising new drugs for treatment of Chagas disease [1,4,43–45].
Studies have suggested that the variable levels of cruzipain
activity correlate to degrees of metacyclogenesis, cellular invasion
and virulence of T. cruzi isolates. Comparison of TcI and TcII
strains suggested that cruzipain proteolytic profiles could be useful
for separating members of these two DTUs and that high
expression levels could be linked to enhanced metacyclogenesis
and cell infectivity [46]. In a study using flow cytometry and anti-
cruzipain antibody both TcI and TcII isolates showed heteroge-
neous surface cruzipain patterns, however, expression levels were
higher in TcI isolates showing higher metacyclogenesis [47]. In T.
cruzi Dm28c (TcI), cruzipain are down regulated during
metacyclogenesis [48]. The over expression of this enzyme
throughout the parasite life-cycle was associated with enhanced
metacyclogenesis but not with increased cell infectivity [49].
Differences in cruzipain expression were correlated with differen-
tial virulence for mice of T. cruzi isolates of Z3 (TcIII and IV) [50].
A proteomic analysis suggested that significant differences in the
expression of cruzipain by isolates of TcIII and TcIV (Z3) could
also contribute to their differential infectivity to cells [51].
Interestingly, proteolytic activity was lower in the virulent T. cruzi
CL strain compared to the non-virulent CL-14 clone [52].
Overall, these studies pointed toward noteworthy but still
controversial association between levels of cruzipain expression/
activity and virulence, metacyclogenesis and cell infectivity of T.
cruzi strains. Low levels of activity and transcripts of CATL-like in
T. rangeli (rangelipain) were related to lack of pathogenicity and
intracellular development [53]. However, a broad study demon-
strated that isolates of divergent lineages of T. rangeli express high
levels of enzymatic activity and transcripts of rangelipain [54].
The major cruzipain isoform has been the subject of extensive
biochemical, structural and immunological studies. However, to
date, sequences of cruzipain-encoding genes were not yet
comparatively examined in T. cruzi isolates of all DTUs displaying
different degrees of cellular invasion, virulence and pathogenicity.
Despite limited to a few strains and lacking sequence analysis,
studies suggested relevant diversity of cruzipain genes [55,56].
Genetic diversity and activity of enzymes from T. cruzi of all DTUs
and T. cruzi-like species need to be investigated. An understanding
of the expression, repertoires and evolutionary relationships of
genes encoding cruzipain in T. cruzi of different DTUs and closest
related T. cruzi-like species, and comparison with T. rangeli and T.
b. brucei, which are phylogenetically distant from T. cruzi with life
cycles (which are phylogenetically distant from T. cruzi and unable
to develop within mammalian cells in vitro), whose life cycles differ
in vertebrate hosts and vectors and differing in vertebrate hosts
and vectors, can assist in clarifying the potential role of these
enzymes in the host-parasite interactions, virulence and pathoge-
nicity.
Comparative studies between closely related pathogenic (T.
cruzi) and non-pathogenic trypanosomes (T. cruzi-like) can
contribute for understanding the evolution of the pathogenicity
and virulence of T. cruzi and can be helpful for successful design of
control, diagnostic and genotyping strategies. With these purpose,
our goals in this study were: to characterize the repertoire of genes
encoding cruzipain from isolates of all T. cruzi DTUs and compare
them with homologues from T. c. marinkellei, T. dionisii, T. rangeli
and T. b. brucei; to analyze the relationships among these genes by
network genealogies; to investigate their genomic organization by
synteny analysis of loci containing cruzipain genes in trypanosome
genomes; to assess the expression of cruzipain homologues by the
non-pathogenic T. cruzi-like species by northern-blotting and
proteolytic assays.
Results
Comparison of whole Genes Encoding CATL Enzymes in
Distinct T. cruzi DTUs, T. dionisii, T. rangeli and T. b. brucei
Like mammalian papain-like enzymes, CATL enzymes of
trypanosomatids are synthesized as inactive precursors, consisting
of pre, pro, and catalytic domains (cd), and a C-terminal
extension. Proteolytic cleavage of the N-terminal pro-domain
generates the mature enzyme consisting of a cd domain and a C-
terminal extension unique of trypanosomatids [24,26]. To
compare the entire cruzipain sequences (,450 amino acids),
sequences from T. cruzi Sylvio X10.6 and G (TcI), Y and
Esmeraldo cl3 (TcII), M6241 cl6 (TcIII), CL Brener (TcVI, one
sequence from each the Esmeraldo-like and non-Esmeraldo-like
haplotypes) and from Tcbat 1994 were aligned with homologous
sequences from T. c. marinkellei 344 and T. dionisii 211. Sequences
Diversity and Genealogy of Cruzipain Genes
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from non-Schizotrypanum species (T. rangeli and T. b. brucei) were
included in the alignments [54].
Overall identities were high in the N-terminal region, either in
pre- and pro-domains (,94 and 91%, respectively) and catalytic
domains (,90%), and most variable in the C-terminal regions
(,85%) (Fig. 1). As typically found in peptidases of Clan CA,
which are targeted to intracellular compartments and secreted, all
cruzipain and homologous genes have a signal peptide at their N-
terminal region, as well as the catalytic triad of cysteine, histidine
and asparagine residues (Cys25, His159 and Asn179) and the
highly conserved Trp181. Important sites for autocatalytic
cleavage, the motifs ERFNIN-like and GNFD-like of pro-domains
are conserved in all trypanosomes. The clan CA is characterized
by having substrate specificity defined by the S2 pocket. In
cruzipain genes from all T. cruzi DTUs and homologues from T. c.
marinkellei, the S2 subsites are conserved whereas in T. dionisii, T.
rangeli and T. b. brucei divergent amino acids were found in these
regions, suggesting differences in substrate specificities (Fig. 1).
Cruzipain amino acid sequences from T. cruzi isolates were
relatively conserved in all domains. The ratio of non-synonymous
(dN) to synonymous (dS) substitutions in the catalytic domain was
dN/dS ,1 by comparing the distinct DTUs of T. cruzi and T. cruzi-
like species, suggesting that the enzymatic domain of cruzipain
genes has been subjected to stabilizing selection for the conser-
vation of metabolic function within the subgenus Schizotrypanum.
Sequences encoding homologous cruzipain genes of T. c. marinkellei
were closely related to those of T. cruzi (,6.5% divergence) but the
divergences were larger than those separating the T. cruzi DTUs
(maximum of ,2.5%). Sequences from T. cruzi largely diverged
from homologues of T. dionisii (,20%), T. rangeli (,33%) and T. b.
brucei (,43%) in all domains (Fig.1). Genealogies based on whole
cruzipain genes, or restricted to pre-pro or to catalytic domains,
resulted in identical topologies (Fig. 2).
Genealogy of Genes Encoding T. cruzi Cruzipain and
Homologues from T. c. marinkellei, T. dionisii and Non-
Schizotrypanum Trypanosome Species
To study the relationships of cruzipain genes from all T. cruzi
DTUs, T. c. marinkellei and T. dionisii, and homologues from T.
rangeli and T. b. brucei (Table 1), we aligned ,500 bp cdCATL
sequences obtained in this study with the corresponding genes
from T. cruzi CL Brener (Esmeraldo-like and non-Esmeraldo-like
haplotypes), Esmeraldo cl3, JR cl4, M6241 cl6 and Sylvio X10.6.
The analyses of either amino acid (Fig. 3) or nucleotide sequences
(data not shown) generated networks of cruzipain genes with
similar topologies. Sequences of cd-cruzipain from all T. cruzi
DTUs always clustered together in a homogeneous assemblage
(,1.2% amino acid sequence divergence) separated from T. c
marinkellei (5.5% divergence), and largely divergent from the cluster
formed by T. dionisii from Brazil (20%) and Europe (21%). Amino
acid sequences of cruzipain genes of all Schizotrypanum species
clustered together and largely separated (28%) from the homol-
ogous genes of T. rangeli and T. b. brucei (Fig. 3; Table 1).
Polymorphism of Cruzipain Gene Copies within Isolates
and DTUs of T. cruzi
Any attempt to associate cruzipain polymorphisms with
biological features of T. cruzi requires a good appraisal of the
diversity of gene copies within both one strain/isolate and each
DTU. We have assessed the polymorphism on cruzipain gene
copies by comparing 3 to 8 sequences from each isolate. Larger
number of sequences (7–8) was analyzed from the isolates of
hybrid DTUs TcV and TcVI (Table 1). Cruzipain gene copies
(paralogous) from isolates of TcI, TcIII, TcIV and Tcbat were
identical or highly similar in their amino acid sequences (Fig. 3),
whereas diverged in 2 to 6 polymorphic sites in their nucleotide
sequences (Fig. 4). We identified a total of 23 variant sequences of
cruzipain sequences (Fig. 4). Relatively homogeneous but not
identical copies were found by comparing sequences from 6
isolates of TcI and two of TcII. No polymorphic sites were found
among sequences from 3 isolates of each TcIII and TcIV.
Sequences from Non-Esmeraldo-like haplotype of CL Brener were
identical to those of TcIII (Fig. 4).
Results disclosed high nucleotide polymorphism on cruzipain
gene copies of the heterozygous hybrids assigned to TcV (3
isolates, 4 to 8 sequences of each) and TcVI (3 isolates, 24
sequences). Different sequences were found in TcV (at least 6
sequence types) and TcVI (8 types), including sequences identical
to those found in TcII or TcIII, sequences found in both TcV and
TcVI, and sequences so far detected exclusively in TcV or TcVI
(Fig. 3, 4).
Distinguishing DTUs of T. cruzi according to
Polymorphisms on Catalytic Domain of Cruzipain Genes
We evaluated the suitability of the polymorphism on nucleotide
sequences of catalytic domain (cd) of cruzipain genes in
distinguishing among the T. cruzi DTUs by comparing 80
sequences from 25 isolates of all DTUs (66 sequences from 22
isolates were determined in this study). Sequences differed by 17
polymorphic nucleotide sites and were divided in 5 major types in
addition to the hybrid sequences from TcV and TcVI (Fig. 4).
Despite polymorphisms within DTUs, unique polymorphic sites
distinguished all DTUs. Cruzipain polymorphisms also distin-
guished Tcbat from all established DTUs (Fig. 4).
To evaluate the suitability of cruzipain polymorphisms as
markers for genotyping, we examined at least three isolates from
each DTU, excepting TcVI for which CL Brener and CL 14 were
analyzed. Despite multiple copies and small polymorphisms
among repeats within the same DTUs and even the same strain
(Fig. 4), cruzipain encoding genes showed high sequence
conservation of catalytic domains from isolates of the same
DTU and clustering of sequences was according to DTUs. Thus,
the cruzipain analysis agreed with genotyping methods based on
either multiple copy or single copy gene markers [6]. In contrast,
large polymorphism and unique sequences detected in each TcV
and TcVI (Fig. 4) suggested that these markers can be valuable to
detect hybrids. Nevertheless, the use of cruzipain genes for T. cruzi
genotyping demands the sequencing of several PCR-amplified
sequences and comparison of homologous sequences through
phylogenetic analyses. A method based on PCR-RFLP analysis of
cruzipain genes has been currently developed to facilitate the use
of cruzipain as marker for T. cruzi genotyping [Lima et al., in
preparation].
Genomic Organization and Synteny of Cathepsin-L Genes
in Trypanosome Species
Previous studies showed that cruzipain genes are organized in
the genomes of trypanosomes as tandem arrays of duplicated and
polymorphic genes located in two or more chromosomes [25].
Analysis of the genomic organization of cruzipain genes in T. cruzi
CL Brener Esmeraldo-like and non-Esmeraldo-like haplotypes
disclosed polymorphisms in number and organization of genes
encoding cruzipain (cruzipain, cruzipain 2 and other putative
isoforms). There was substantial variation in number, sequence,
chromosome and position of the duplicate genes of the two
haplotypes; Esmeraldo-like showed 1–4 cruzipain repeats dis-
Diversity and Genealogy of Cruzipain Genes
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persed in three loci and non-Esmeraldo-like present 3–5 copies in
three loci (data from TriTrypDB).
Chromosome segments from the genome of T. cruzi CL Brener
(TcVI) containing three and four tandem copies of cruzipain in
Esmeraldo and non-Esmeraldo haplotypes, respectively, were
Figure 1. Alignment of predicted amino acid sequences from entire cruzipain of T. cruzi (TcI, TcII, TcIII, TcVI and Tcbat) and
homologues from T. cruzi-like (T. c. marinkellei and T. dionisii), T. rangeli and T. b. brucei. Pre, pro, catalytic domain and C-terminal extension
amino acid sequences of cruzipain genes from T. cruzi Sylvio X10.6 and G (TcI), TCC1994 (Tcbat), Y and Esmeraldo cl3 (TcII), M6241 cl6 (TcIII), CL Brener
(TcVI) Non-Esmeraldo-like (TcIII) and Esmeraldo-like (TcII) haplotypes and homologues from T. c. marinkellei (344), T. dionisii (211), T. rangeli (LDG and
AM80) and T. b. brucei (TREU 927). The CATL family signatures of pro-domain motifs ERFININ (ERFN) and GNFD (GTFD) are indicated in bold and
underlined, the subsites S1, S2 and S29 are in bold, and the conserved Trp181 are indicated by (*).The glutamine [Q] of the oxyanion hole, cysteine [C],
histidine [H] and asparagine [N] of catalytic triad in the catalytic domain, and 8 cysteines in the C-terminal extension are indicated by arrow heads.
doi:10.1371/journal.pone.0038385.g001
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compared with data from the genome drafts of T. cruzi G (TcI),
M6241 cl6 (TcIII) and T. dionisii. Homologous segments of
chromosome 6 from T. cruzi CL Brener containing cruzipain
repeats were found in the genomes of other T. cruzi strains: one
cruzipain gene copy from T. cruzi G (of three copies detected in the
genome) and three from M6241 cl6 (6 copies in the genome). In
the genomes of these strains, cruzipain and homologous genes
were flanked by five orthologous genes thus constituting a syntenic
block (Fig. 5). Homologous cruzipain genes arranged in the same
order were detected in the genomes of T. dionisii (two out of three
copies found in the genome draft) and T. b. brucei (an array of 11
identical copies of brucipain in the chromosome 1) (Fig. 5). This
syntenic block was selected for this study considering the
positioning of cruzipain gene copies from distinct T. cruzi strains
and the synteny shared with T. dionisii, T. b. brucei (Fig. 5) and other
trypanosome species as showed with T. vivax and T. congolense
genome drafts (data not shown).
Assembly of repetitive sequences in tandem arrays is very
problematic, and both the copy number and position are very
difficult to be accurately determined. Miss-assembly from
collapsed repeat sequence frequently arises during automated
genome assembly when small sequence reads originating from
distinct repeat copies are incorrectly joined to generate a single
unit. This artefact could not be ruled out in the genome drafts
analyzed. To avoid mis-assembled genes, we selected contigs
containing sequences from both cruzipain and adjacent ortholo-
gous genes, which warrant the positioning of the genes encoding
cruzipain in this syntenic region (Fig. 5). The degrees of sequence
identity between each syntenic gene (Fig. 5) agreed with the
phylogenetic relationships among all trypanosome species inves-
tigated: T. cruzi, T. c. marinkellei, T. dionisii, T. rangeli and T. b. brucei
[7,10,11,14,21,54].
Comparative Expression Analyses of Cruzipain and
Homologues in T. cruzi-like and T. rangeli by Northern
Blot Hybridization and Detection of Proteolytic Activity in
Gelatin Gels
To assess the expression of cruzipain and homologous enzymes
from virulent and non-virulent and human-infective or bat-
restricted trypanosome species, developing or not within cells, total
RNA from epimastigotes of Schizotrypanum species (T. cruzi Y, T. c.
marinkellei and T. dionisii) and T. rangeli was compared by northern-
blot hybridization using T. cruzi Y derived catalytic domain
Figure 2. Network genealogies of predicted amino acid sequences from all domains of genes encoding cruzipain in T. cruzi and
homologues in other trypanosome species. Networks produced using the Neighbour-Net algorithm in SplitsTree v4.11.3, excluding all
conserved sites and with Uncorrected p-distance. Networks were produced using entire sequences (A), pre- and pro-domains (B) or restricted to
catalytic domains (C) of cruzipain encoding genes from the different trypanosomes are indicated by different symbols and colors according to the
legend. Numbers in nodes correspond to support values estimated by performing 100 bootstrap replicates using the same parameter optimized for
network inferences.
doi:10.1371/journal.pone.0038385.g002
Diversity and Genealogy of Cruzipain Genes
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Figure 3. Network and polymorphism analyses on catalytic domain of cruzipain genes from different trypanosome species. Genes
from Schizotrypanum species (T. cruzi, T. c. marinkellei and T. dionisii) were compared with homologues from their closest relative species, T. rangeli,
and the distant related T. b. brucei. (A) Network of 33 amino acid predicted sequences constructed using the Neighbour-Net algorithm excluding all
conserved sites and with Uncorrected p-distance. The numbers in nodes correspond to bootstrap values from 100 replicates. (B) Polymorphism on
cruzipain amino acid sequences from the distinct trypanosome species.
doi:10.1371/journal.pone.0038385.g003
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Figure 4. Polymorphism and network analyses of catalytic domain sequences of cruzipain genes from T. cruzi isolates of TcI-VI and
Tcbat. (A) Polymorphic nucleotide sites on catalytic domains of cruzipain encoding genes; (B) Network based on polymorphic nucleotides
constructed with the Neighbour-Net algorithm excluding all conserved sites and with Uncorrected p-distance. The numbers in nodes correspond to
bootstrap values from 100 replicates. CLBrener1-5 are sequences from TriTrypDB: Tc00.1047053509429.320, Tc00.1047053507537.20,
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cruzipain probe that strongly cross-hybridized with RNA from
other T. cruzi strains (G, CL and JJ) and from all other
trypanosome species using low stringent conditions (data not
shown). However, hybridization signals using more stringent
conditions correlated very well with sequence identity displaying
high cross-hybridization signal with transcripts of T. cruzi,
moderate hybridization with T. c. marinkellei, weak hybridization
signal with transcripts of T. dionisii and lack of hybrization with T.
rangeli isolates. This analysis allowed estimation of transcripts of
similar size (,1.9 Kb) for all the Schizotrypanum species (Fig. 6). In
agreement with the differential cross-hybridization among the
transcripts of different species, we previously demonstrated that a
probe consisting of T. rangeli catalytic domain of CATL
(rangelipain) strongly hybridized with T. rangeli while cross-
hybridization with Schizotrypanum species was very weak [54].
Cruzipain, a glycoprotein of ,50–60 kDa, is post-transcrip-
tionally regulated during the T. cruzi life cycle [4,24,26]. Here,
proteolytic activities related to CATL were detected in epimasti-
gote lysates of all Schizotrypanum species examined (Fig. 6B). In gels
incubated at pH 5.0 with 5 mM DTT (a condition found to be
Tc00.1047053507603.270, Tc00.1047053507603.260 and Tc00.1047053507537.10; *GenBank accession numbers of all sequences included in these
analyses are listed on Table1. Major types of sequences from T. cruzi isolates of different DTUs are indicated by different colors according to the
legend.
doi:10.1371/journal.pone.0038385.g004
Figure 5. Synteny of a locus containing cruzipain genes in T. cruzi, T. dionisii and T. b. brucei. Segments from the chromosome 6 of T. cruzi
CL Brener non-Esmeraldo-like and Esmeraldo-like haplotypes, corresponding to TcIII and TcII, respectively, showing 3 to 4 cruzipain gene copies
(entire or partial) flanked by orthologous genes marked with different colors according to the legend. Data from the draft assembly of T. cruzi G,
M6241 cl6 and T. dionisii allowed to place one, three or two cruzipain gene copies, respectively, within the same syntenic region (figure do not reflect
their actual position on chromosomes). Syntenic region from the chromosome 6 of T. b. brucei comprising 11 copies in tandem of brucipain genes
was included in the alignment. The shades of vertical gray bars indicate the variable degrees of divergence between sequences according to the
legend. The accession codes of all contigs/scaffolds and GenBank accession numbers (in bold) are presented below the corresponding sequences.
doi:10.1371/journal.pone.0038385.g005
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optimal for the detection of cysteine proteases in these trypano-
somes), remarkable high activities resolving in the region of,55 to
35 kDa were detected in lysates of T. c. marinkellei and T. dionisii.
Lower cruzipain activity was detected for T. cruzi G of TcI
compared to T. cruzi-like trypanosomes (Fig. 6A). We have
detected distinct profiles and comparable activity levels for all T.
cruzi strains such as the virulent Y and CL (TcII) (data not shown)
and the non-virulent JJ (TcIV) [54] using the same conditions for
the activity assays (data not shown). Weaker activity was detected
in T. rangeli, confirming lower expression of rangelipain compared
to cruzipain as previously demonstrated [54]. All activities were
fully inhibited by the cysteine protease-specific inhibitor E-64, thus
corroborating the activity of CATL enzymes (Fig. 6B).
Discussion
In this study, we compared cruzipain-encoding genes of T. cruzi
isolates representatives of all known subspecific phylogenetic
diversity, including all DTUs (TcI-TcVI) and the new T. cruzi
genotype Tcbat, as well as homologous genes from T. cruzi-like
species, T. c. marinkellei and T. dionisii, the closest relatives of T.
cruzi. Results demonstrated that cruzipain genes from a large set of
T. cruzi isolates representative of the overall biological and genetic
diversity compared with homologous CATL genes from other
species in a phylogenetic framework disclosed divergences that
closely parallel their phylogenetic diversity [5–7,10,11,14,57]. Our
findings revealed species-specific and DTU-specific variability that
may be valuable for elucidation of the roles of cruzipain in host-
parasite interactions, virulence and pathogenicity evolution.
Isolates of T. cruzi show a range of variation in important
biological, immunological, pathological (morbidity and mortality)
and clinical characteristics [5,6]. It is likely that much of this
variation is probably due to genetic differences among isolates that
can be related to specific DTUs. The genomes of the ‘‘non
virulent’’ T. cruzi Sylvio X10/1 (TcI) and ‘‘virulent’’ T. cruzi CL
Brener (TcVI) are highly similar in their gene-dense ‘‘core’’ coding
regions, which show strongly conserved synteny interspersed with
variable repetitive sequences [58]. Large differences within and
among DTUs have emerged in several repetitive gene families
such as cysteine proteases, mucins, trans-sialidases, surface
protease gp63 and amastigote surface glycoproteins (amastins)
[58–61].
In this study, a relevant conservation of amino acid sequences of
genes encoding cruzipain was found among T. cruzi of all DTUs,
Tcbat and T. c. marinkellei compared to more divergent sequences
from T. dionisii. Cruzipain sequences from all these species tightly
clustered together and were more related to rangelipain from
T. rangeli than to brucipain of T. b. brucei. Notwithstanding hard
efforts to find sequences homologous to cruzipain 2, no sequences
were found that displayed the signature residues identifying this
isoform [28]. Besides sequences homologous to major cruzipain,
which comprised the largest part of sequences detected, our
searches in the genome data banks and PCR-amplified sequences
disclosed a few heterogeneous sequences closely related to
cruzipain 2 [Lima et al., in preparation] but lacking the signature
residues reported as characteristics for the archetype of this
isoform. Variations in residues in the S2 pocket may account for
peculiar activity and substrate specificity of cruzipain isoforms,
hence, detailed biochemical studies will be necessary to assess
expression, activity and functions in order to verify whether these
sequences encode new isoforms or variants of cruzipain 2. In any
case, our findings confirmed that phylogenetic analyses are
valuable to discover new cruzipain isoforms and/or variants as
recently shown for congopain variants through combined genetic
and functional approaches [62].
In network genealogies, sequences of cruzipain from the same
species, as well as from strains/isolates of the same phylogenetic
lineages, always clustered together. Even with the high degree of
conservation in cruzipain genes from all DTUs, polymorphisms on
nucleotide sequences from the catalytic domain of cruzipain
generated 5 branches within T. cruzi, each one comprising
sequences from one DTU (TcI-TcVI) or Tcbat. In general,
sequences from cruzipain gene copies within the same DTU
showed small or no variation at all, as we verified for isolates of
TcI-TcIV. Data from these DTUs were consistent with their
epidemiology and evolutionary histories, with distances among
cruzipain genes suggesting that they have had more time
segregated from each other than the more recently emerged
Figure 6. Comparative expression analysis of cruzipain and homologues in T. cruzi, T. cruzi marinkellei, T. dionisii and T. rangeli. (A)
Northern blotting analysis of cruzipain transcripts from T. cruzi (Y) and cross-hybridization using the probe consisting of PCR-amplified catalytic
domains of T. cruzi Y cruzipain labeled with 32P T. cruzi Y (TcY-CatL probe); agarose gel of RNA used for this analysis was stained with ethidium
bromide (EtBr). (B) CATL proteolytic activities detected in epimastigote lysates of T. cruzi G, T. cruzi marinkellei, T. dionisii and T. rangeli. Activity
banding profiles detected in gelatin gels, pH 5.0 and 5 mM DTT were inhibited in gel incubated with 10 mM E-64.
doi:10.1371/journal.pone.0038385.g006
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TcV-TcVI. Isolates of the same DTUs appear to have had a long
association with preferential mammalian hosts and vectors and,
consequently, naturally circulate separated by biological, ecolog-
ical and geographical barriers [5–7,63,64]. TcV and TcVI were
confirmed as formed by heterozygous isolates exhibiting polymor-
phic cruzipain sequences, in addition to sequences identical to
those of putative donors TcII or TcIII. In agreement with their
hybrid origin, sequences from TcV and TcVI clustered with TcII
or TcIII forming a reticulate pattern in the network genealogy of
cruzipain genes. Tandem arrays of cruzipain genes in T. cruzi CL
Brener genome showed sequences apparently derived from TcII
(Esmeraldo-like) and TcIII (Non-Esmeraldo-like), even within a
single locus. Unique sequences detected in TcV or TcVI strains
could be due to the fact that these strains originated from
hybridization between strains of TcII and TcIII not included in
this study. In addition, more heterogeneous and unique sequences
within hybrid strains could emerge post-hybridization through
homologous recombination. Our results corroborate that TcV and
TcVI resulted from the hybridization between TcII and TcIII as
hypothesized before using other markers. Studies have been
performed to better understand the role of hybridization events in
shaping the genetic diversity within T. cruzi [65–67]. Our findings
confirmed Tcbat as a new T. cruzi genotype not yet assigned to any
DTU. Sequences from Tcbat clustered closest to TcI but
separated from all DTUs as demonstrated with other markers
[6,7,68].
Genealogy of cruzipain and homologous genes inferred in this
study confirmed T. c. marinkellei isolates as closest relative and
outgroup for T. cruzi isolates, as previously shown by examination
of other genes including SSUrRNA, gGAPDH and Cytb
[10,14,22]. In a comparative proteomic analysis, T. c. marinkellei
was indistinguishable from T. cruzi reinforcing their very close
relatedness [69]. To date, Tcbat, T. c. marinkellei and T. dionisii
have been found exclusively in bats and all invade and develop in
culture cells of a variety of mammals. Tcbat was infective to mice,
despite very low virulence. However, these three bat trypanosomes
have been reported to be incapable of development in triatomine
species commonly infected by T. cruzi [7–10,14,16].
Evolutionary studies of cruzipain and homologous genes from
other trypanosome species corroborated phylogenetic relationships
based on SSUrRNA and gGAPDH genes of all species investi-
gated: T. carassii from fish [70], T. rangeli [54], T. vivax [71] and T.
theileri [72,73], the later three from mammals. Evolutionary
relationships of cruzipain and homologues from these trypano-
some species indicated that this gene family expanded by
successive gene duplications followed by divergences giving rise
to genes with greater similarity when originated from the same
rather than distinct species/genotypes. This suggests that concert-
ed evolution is a widespread homogenizing force in this
trypanosome multigene family. Consequently, CATL-like gene
duplicates (paralogous) of all trypanosome species examined
clustered by species, i.e. like orthologous genes in different species,
as shown for several repeated genes in tandem arrays from African
trypanosomes [74]. However, gene conversion and positive
selection can generate diversity in sequence, quantity and order
among tandemly repeated genes as showed in this and in previous
studies on trypanosomatids [59–61,74].
Results from this study disclosed molecular markers able to
identify the phylogenetically closely related T. cruzi and T. cruzi-
like species. Reliable identification and knowledge of the diversity
and epidemiology of these species are crucial to understand the
shared evolutionary history of T. cruzi and T. cruzi-like bat
trypanosomes [7,10,11,14,57]. We have previously shown that T.
cruzi and T. rangeli [54], T. vivax [71] and T. theileri [72] could be
diagnosed by specific PCR assays targeting cruzipain sequences. In
this study, we demonstrated that cruzipain sequences clustered T.
cruzi isolates according to DTUs, similarly to CATL-like gene
based genotyping of lineages within T. rangeli [54], T. vivax [71]
and T. theileri [72,73]. Altogether, these previous studies and results
herein described support the use of these genes as valuable
markers for both inter- and intra-species phylogenetic analyses of
trypanosomes.
There are clear evidence that immunization with cruzipain
catalytic domain, and not with C-terminal domain, confer
important cellular protective immunity against T. cruzi, as
evidenced by the reduction in parasitemia, tissue parasitism and
mortality in mice, indicating the existence of epitopes important
for protective immunity in the catalytic domains and, thus,
supporting the use of cruzipain for vaccine development [34–37].
The main goal of all vaccination strategies should be a polyvalent
vaccine against infection by different strains of T. cruzi of any
DTU. Although the polymorphism among cruzipain catalytic
domains expressed by distinct strains appears to be reduced, for
vaccination purposes it is important to evaluate strain-variant and
conserved cross-reactive epitopes in different T. cruzi DTUs, and
among strains of the same DTU, and the possible relevance of
epitope polymorphism for species- or strain-specific protective
immune response [75–77]. Therefore, knowledge on the genetic
diversity within the plethora of DTUs and strains of any antigen
vaccine candidate for Chagas disease can be decisive for the design
of efficient and polyvalent vaccines using, if necessary, a pool of
stage- and strain-specific antigens. Here, we showed for the first
time that all the six DTUs, and even different strains of DTUs,
exhibited specific genetic variants of cruzipain. Any possible
implications of the cruzipain polymorphisms to warrant efficient
cross-protection of a potential vaccine require investigations to
demonstrate the immunogenicity of cruzipain variants from
different T. cruzi DTUs.
Drugs currently employed for the treatment of Chagas disease
have serious limitations due to their failure in chronic patients and
side effects. Inhibitors of cruzipain kill the parasite and cure
infected mice, thus validating this enzyme as a very promising
target for design of new drugs [1,2,4,43,44]. In this study, we
demonstrated that substrate-binding subsites of cruzipain are
conserved in all T. cruzi DTUs, but diverge in T. dionisii and other
trypanosome species. T. c. marinkellei cruzipain share identical
subsites and, hence, can be a valuable non-infective to human
model to test drugs against trypomastigotes and intracellular
amastigotes. The efficacy of the cruzipain inhibitor K777 was
evidenced against 6 T. cruzi strains differing in tissue tropisms and
drug susceptibility [44]. More strains must be tested to verify the
efficacy of inhibitors for the ample diversity of cruzipain variants
expressed by T. cruzi of the different DTUs.
Characterization of genes encoding major cruzipain, genealo-
gies of genetic variants and genomic organization were addressed
in this study for the first time to compare T. cruzi of all DTUs and
closest related T. cruzi-like species. This is the most comprehensive
study using sequences from protein-encoding genes to compare
isolates of T. cruzi from all DTUs. Of the strains selected for
genome sequencing CL Brener and Esmeraldo are virulent
whereas Sylvio X10.6 and G strain are considered of low
virulence. Most T. cruzi isolates examined here by PCR-
amplification of cruzipain genes were also previously analysed
regarding virulence for mice: TcI, Tcbat and TcIV isolates were
non-virulent whereas TcIII (TCC1386) and TcV (TCC197)
isolates showed to be virulent for mice (data not shown).
Interestingly, non-virulent CL14 clone was shown in this study
to be a hybrid strain like the virulent CL Brener [52]. All the six
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DTUs were supported by cruzipain gene markers. Infections
caused by different strains of T. cruzi from distinct DTUs
extensively diverged in the morbidity and mortality. Attempts to
associate T. cruzi DTUs with behavioral phenotypes, including
virulence and pathogenicity in mice, metacyclogenesis and cell
infectivity, suggested an important degree of association [5,6,60].
However, besides some overlap between different DTUs, there is a
broad intra-DTU phenotypic diversity (largest differences have
been reported within TcI) and even among clones of a given strain
such as the virulent CL Brener and non-virulent CL14 clones,
both of TcVI. Therefore, we can associate cruzipain polymor-
phisms to DTUs. However, available data are insufficient to
support strong correlations between behavioural phenotypes and
DTUs. This goal will require extensive studies of T. cruzi strains
from all DTUs through a combination of phylogenetic, biochem-
ical, pathological and immunological approaches.
Our findings indicated conserved major cruzipain in T. cruzi of
all DTUs while other trypanosome species express diverse
homologous enzymes. Results showed, for the first time, the
expression of cruzipain transcripts by T. c. marinkellei and T. dionisii
that correlated very well to sequence divergences among all
trypanosome species investigated and, in addition, revealed high
proteolytic activity in these two non-pathogenic species. An
understanding of the cruzipain gene repertoires, expression and
functions can help to elucidate the evolutionary history that
shaped variability within T. cruzi and its divergence from T. cruzi-
like species and the more distantly related T. rangeli. T. cruzi-like
trypanosomes, despite sharing genomic and proteomic features
[10,11,14,69], exhibit many peculiarities that can potentially
explain differences in host preference/restriction, virulence and
pathogenesis. Results from this comprehensive study on major
cruzipain isoform are the initial steps toward understanding the
roles played by genetic repertoires of cruzipain enzymes and
homologues in the life cycles and infections caused by T. cruzi of all
DTUs, T. cruzi-like species and T. rangeli.
Materials and Methods
PCR Amplification, Sequencing and Phylogenetic
Analysis of CATL Sequences
The whole sequences of cruzipain genes (,1.4 Kb) of T. cruzi
Esmeraldo cl3 and CL Brener were retrieved from TriTrypDB.
Homologous genes in T. cruzi M6241 cl6 (Project ID:59941) were
obtained from the genome drafts produced by the Genome
Institute at Washington University School of Medicine (St. Louis,
USA). T. cruzi G, Tcbat 1994, T. dionisii 211 and T. rangeli AM80
were obtained from genome drafts that we are currently
performing using standard pyrosequencing shotgun methodology
according to Roche 454 protocols as described previously [78].
Resulting reads were submitted to Roche’s Newbler software
(version 2.3) and contigs containing genes described in this study
were assembled in scaffolds (Table 1). Sequences retrieved from
genome data banks were aligned with homologues from T. cruzi
Sylvio X10.6 and Y, T. rangeli LDG and T. b. brucei TREU 927
from GenBank and T. c. marinkellei 344 determined in this study.
The whole sequence from T. c. marinkellei was obtained by PCR-
amplification using the primers TDIO5-FOR (59 ATG ACG
AGC TGG GCG CGT G 39) and CATL3REV2 (59 TTA GCT
TCA GGA GCG GCG ATG 39) and the conditions described
previously [54,71]. Cathepsin L sequences determined in this
study are available in GenBank (Table 1).
PCR products from catalytic domain of cruzipain genes (cd-
cruzipain) obtained using primers and reaction conditions
described previously [54,71] were cloned, and 3 to 8 clones from
each species/isolates were sequenced. Alignment of sequences
encoding cd-cruzipain genes includes 14 sequences from data
banks and 66 determined in this study of all DTUs (TcI-TcVI),
Tcbat and homologues from T. c. marinkellei and T. dionisii from
Brazil and England [7,14]. Sequences from non-Schizotrypanum
trypanosomes, T. rangeli isolates (SA, AM80, PG, 643, 1719 and
LDG) representative of its major lineages [21,22], and T. b. brucei
were also added in the alignment. Sequences determined in this
study reflecting the spectrum of genetic polymorphism observed
were deposited in GenBank (Table 1). All sequences employed in
this study are listed in Table 1.
We initially performed a broad search in all available genomes
aiming to detect cruzipain isoforms. Most sequences were
homologous to the major cruzipain, and no sequences showed
the amino acid residues typical of cruzipain 2. A significant
number of sequences from distinct strains of T. cruzi, including
those obtained by PCR-amplification were found to be different
from cruzipain and cruzipain 2 (data not shown). For genealogy
analysis, we selected only sequences with the signatures of
cruzipain (Fig. 1), thus removing some sequences of other putative
isoforms. Sequences were aligned using Clustal X [79] and
manually adjusted. The amino acid sequence of cruzipain was
used as a template to ensure codon-to-codon correspondence.
Phylogenetic relationships were inferred using nucleotide and
predicted amino acid sequences from the entire genes or restricted
to pre-pro or cdCATL domains. Network genealogy was inferred
in SplitsTree v4.11.3 using the neighbor-net method [80].
Internode supports were estimated by performing 100 bootstrap
replicates using the same parameters optimized for network
inferences.
Synteny and Codon Analyses
Syntenic genes flanking CATL genes were identified in the
genomes of T. cruzi CL Brener (Non-Esmeraldo-like and
Esmeraldo-like haplotypes) and T. b. brucei 927 genomes
(TriTrypDB). Scaffolds comprising cruzipain genes from T. cruzi
G and M6241 cl6 and homologues from T. dionisii were aligned
with these syntenic segments. Search on the draft genome of Sylvio
X10/1 [58], Tcbat 1994 and T. rangeli AM80 disclosed cruzipain
sequences, most partial, in small reads that could not be positioned
in homologous scaffolds. The ratio of non-synonymous to
synonymous (dN/dS) amino acid changes was calculated according
to Yang and Nielsen [81] using PAML, v.4.2 software to infer
relative selection pressures [82].
Northern Blot and Proteolytic Activities of Cruzipain
For Northern blot analysis, 10 pg of total RNA extracted using
Trizol (Gibco BRL) from epimastigotes of T. cruzi Y, T. c.
marinkellei 344, T. dionisii 211 and T. rangeli isolates AM80 and SA
was electrophoresed in 1.0% agarose gel and blotted onto nylon
membrane. The membrane was hybridized for 14–16 hr at 40uC
with a probe consisting of PCR-amplified cd-cruzipain of T. cruzi
Y labeled with 32P and washed in 16bufffer (0.3 M NaCl, 0.3 mM
Na citrate, pH 7.0 containing 0.1% SDS) at 50uC for 1 h as
described previously [54].
To assess the proteolytic activities in gelatin gels, lysates of
cultured epimastigotes were subjected to electrophoresis in 10%
resolving SDS-acrylamide gels containing 500 mg/ml gelatin as
described before [54,72]. Briefly, gels were incubated in 2.5% (v/
v) Triton X-100 in 0.1 M buffer (acetate: pH 4.0 and 5.0; Tris-
HCl: pH 7.5) containing 5 mM DTT (dithiothreitol) and then, for
,18 h in buffer-DTT. Maximum activity was detected in pH 5.0
and was greatly stimulated by DTT. Bands associated to cysteine
proteases were identified by incubating gel halves with 10 mM E-
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64. Gels were fixed with 10% TCA, and stained with Coomassie
blue R-250 [54,72].
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